See also this year's filing and all EDGAR filings for this company.
PDF Report 0001355790_2014_International_Stem_Cell_CORP.pdf
Logs
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'PropertyPlantAndEquipmentNet', 'IntangibleAssetsNetExcludingGoodwill', 'DepositsAndOtherAssets', 'CashAndCashEquivalentsAtCarryingValue', 'AccountsReceivableNetCurrent', 'InventoryNet', 'PrepaidExpenseAndOtherAssetsCurrent', 'RestrictedCashAndCashEquivalents', 'AccountsPayableCurrent', 'LiabilitiesCurrent', 'AccruedLiabilitiesCurrent', 'DeferredRevenueCurrent', 'DueToRelatedPartiesCurrent', 'Advances', 'FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue'))"} |
Graph
Absolute values for 0001355790, International Stem Cell CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,626,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,250,000 |
| 2 | PropertyPlantAndEquipmentNet | 830,000 |
| 3 | remainder_Assets | 33,000 |
| 4 | LiabilitiesCurrent | 7,021,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,643,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,033,000 |
| 9 | ResearchAndDevelopmentExpense | 3,560,000 |
| 10 | remainder_Expenses | 2,457,000 |
| 11 | remainder_Revenues | 6,147,000 |
| 12 | remainder_NetIncome | -2,933,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,739,000 |
| 1 | Liabilities | 7,021,000 |
| 2 | Expenses | 13,693,000 |
| 3 | Revenues | 6,147,000 |
| 4 | StockholdersEquity | 718,000 |
| 5 | NetIncome | -10,479,000 |
| 6 | ComprehensiveNetIncome | -10,479,000 |
| 7 | BaseVar | 18,766,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.21 |
| 9 | EconomicCapitalRatio | 1.26 |
Edgar->Model Mapping
Feature Distribution
Change over Time
